Cambridge VIP’s 4th Annual

Clinical Trial Venture, Innovation & Partnering

Investing in the Future of Clinical Trials: Where Innovation Meets Strategic Capital

February 2-3, 2026


As part of the renowned 17th Annual SCOPE Summit, the 2026 4th Annual Clinical Trial Venture, Innovation & Partnering Conference offers a focused, executive-level platform designed for forward-thinking investors, corporate leaders, and entrepreneurs shaping the future of clinical research. This high-impact, boutique event convenes a distinguished audience of C-suite executives from investment firms, growth-stage and mature companies, large pharma, hospitals, and corporate venture arms. With a dual focus on current market dynamics and long-term forecasting, this conference delivers actionable insights into emerging investment trends, scalable innovation strategies, and the evolving landscape of clinical trial partnerships. Attendees will benefit from candid discussions, fireside chats, and curated panels led by industry pioneers, covering capital allocation strategies, innovation pipelines, regulatory tailwinds, and risk-adjusted returns. Explore the exhibit hall featuring high-growth startups and established players, and gain visibility into breakthrough technologies, investment-grade opportunities, and strategic collaborations that will define the clinical trial ecosystem over the next decade. Whether you're seeking to inform your investment thesis, identify acquisition targets, or shape your corporate venture strategy, this event is engineered to support long-term value creation, portfolio growth, and strategic decision-making.


Coverage will include, but is not limited to:

  • Long-Term Investment Strategies
  • Venture Capital Financing Trends
  • Bridging Strategy and Execution
  • Build vs. Buy: How Pharma Makes Strategic Investment Decisions to Accelerate Clinical Development
  • Oncology Innovation: Funding High-Cost, High-Impact Trials
  • Entrepreneurship Lessons & Guidance
  • CEO & Investor Relationships
  • Investing in Women’s Health: Unlocking Opportunities from Clinical Trials to Market
  • Decoding Clinical Trial Operations: What Investors Should Know About Biopharma’s Strategic Spend:
    • Optimizing Study Start-Up
    • Scaling Patient Recruitment & Site Strategy
    • Data Integrity as a Value Driver
    • Strategic Vendor Partnerships
    • Outsourcing of Clinical Research & Services

If you have a compelling story to share with innovators, investors, and executives attending this boutique event, we encourage you tosubmit a speaking proposal.

Please note that the vast majority of speakers are identified, selected, and invited by our summit chairs and advisory board members. As we receive a high volume of submissions, we regret that Cambridge VIP can only be in contact with those deemed optimal candidates.

To become a sponsor, click here.

CONFERENCE CONTENT
Eileen Murphy
Conference Producer
Phone: (+1) 781-247-6268
Email: emurphy@healthtech.com

PARTNERING & SPONSORSHIP
Brian Caine
Manager, Strategic Partnerships
Phone: (+1) 908-809-0946
Email: bcaine@healthtech.com